Interference of Hawthorn on Serum Digoxin Measurements by Immunoassays and Pharmacodynamic Interaction With Digoxin

被引:2
|
作者
Dasgupta, Amitava [1 ]
Kidd, Laura [1 ]
Poindexter, Brian J. [1 ]
Bick, Roger J. [1 ]
机构
[1] Univ Texas Med Sch, Dept Pathol & Lab Med, Houston, TX USA
关键词
HEART-FAILURE; SIBERIAN GINSENG; MEDICINE; EXTRACT;
D O I
暂无
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Context.-Hawthorn is an herb indicated for treating cardiac illness. Because a patient taking digoxin may also take hawthorn, we investigated potential interference of hawthorn in serum digoxin measurements using immunoassays as well as pharmacodynamic interaction between hawthorn and digoxin. Hawthorn contains alkaloids that are structurally similar to digoxin and may interfere with serum digoxin measurement using immunoassays. In addition, hawthorn has cardioactive properties similar to digoxin. Objective.-To study potential pharmacodynamic interaction between hawthorn and digoxin. Design.-The effects of hawthorn extract on serum digoxin measurements using Digoxin III (Abbott Laboratories, Abbott Park, Illinois) and the Tina-Quant digoxin assay (Roche Diagnostics, Indianapolis, Indiana) were investigated using 2 different brands of extract. To study the pharmacodynamic interaction between hawthorn and digoxin, we used an isolated adult rat cardiomyocyte system, measuring calcium transients by real-time fluorescence spectrophotometry. Results.-Hawthorn interfered only with the Digoxin III immunoassay but had no effect on the Tina-Quant assay. Both hawthorn extracts increased intracellular calcium levels, but the lack of additive response with digoxin suggests both may bind to the same site of Na, K adenosine triphosphatase. Conclusion.-Because of interference of hawthorn with a digoxin immunoassay and pharmacodynamic interaction with digoxin, a patient receiving digoxin should avoid hawthorn. (Arch Pathol Lab Med. 2010; 134: 1188-1192)
引用
收藏
页码:1188 / 1192
页数:5
相关论文
共 50 条
  • [31] COMPARISON OF SEVERAL IMMUNOASSAYS WITH THE CDC CANDIDATE REFERENCE ASSAY FOR DIGOXIN IN SERUM
    LEDDEN, DJ
    SHOEMAKER, B
    YEAGER, FM
    SCHROEDTER, DE
    TUDOR, MA
    MARFURT, KL
    LEWIS, LA
    MESSENGER, LJ
    CLINICAL CHEMISTRY, 1985, 31 (06) : 929 - 929
  • [32] Digoxin and Digitoxin-like immunoreactive substances in elderly: Impact on measurement of serum digoxin and digitoxin concentrations by immunoassays.
    Wu, SL
    Li, W
    Wells, A
    Dasgupta, A
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2000, 114 (02) : 301 - 301
  • [33] The interference of spironolactone, canrenone and three metabolites in nine immunoassays for the analysis of digoxin.
    Steimer, W
    Eber, B
    Mueller, C
    CLINICAL CHEMISTRY, 2000, 46 (06) : A192 - A193
  • [34] RADIOIMMUNOASSAY OF SERUM DIGOXIN IN RELATION TO DIGOXIN INTOXICATION
    SINGH, RB
    RAI, AN
    DUBE, KP
    SRIVASTAV, DK
    SOMANI, PN
    KATIYAR, BC
    BRITISH HEART JOURNAL, 1975, 37 (06): : 619 - 623
  • [35] DIGOXIN TOXICITY WITH NEGATIVE SERUM DIGOXIN LEVELS
    Aleem, Saadat
    Al-Sadawi, Mohammed
    Fan, Roger
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2021, 77 (18) : 2119 - 2119
  • [36] Interference of Chinese medicines Chan Su and Danshen with three digoxin immunoassays.
    Datta, P
    Wells, A
    Dasgupta, A
    CLINICAL CHEMISTRY, 2002, 48 (06) : A40 - A41
  • [37] RENAL-DISEASE AND DIGOXIN IMMUNOASSAYS
    MCELNAY, JC
    HOOYMANS, PM
    BRITISH MEDICAL JOURNAL, 1985, 291 (6505): : 1319 - 1319
  • [38] The effect of digoxin and hawthorn on myocyte contractility.
    Bleske, BE
    PHARMACOTHERAPY, 2003, 23 (03): : 392 - 392
  • [39] QUINIDINE-DIGOXIN INTERACTION - INTERFERENCE WITH OTHER DRUGS
    DOERING, W
    WAGNER, J
    KONIG, E
    ZEITSCHRIFT FUR KARDIOLOGIE, 1980, 69 (10): : 717 - 717
  • [40] RENAL-DISEASE AND DIGOXIN IMMUNOASSAYS
    CAPPS, N
    BRITISH MEDICAL JOURNAL, 1985, 291 (6509): : 1649 - 1650